Intervention
galantamine hydrobromide
ClinicalTrials.gov intervention label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov intervention label, found in 9 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
9 shownThe Efficacy of Galantamine on the Attention and the Frontal Function of the Patients With Dementia of Alzheimer TypeNCT00216515 · 2004-03-01
COMPLETEDTreatment of Severe Alzheimer's Disease: Evaluation of Efficacy and Safety of Galantamine Hydrobromide in a Controlled StudyNCT00216593 · 2003-12-01
COMPLETEDA Follow-up Study to Assess Safety and Tolerability of Galantamine Treatment in Individuals With Mild Cognitive ImpairmentNCT00240695 · 2003-05-01
COMPLETEDA Study of the Safety and Effectiveness of Galantamine in Patients With Alzheimer's DiseaseNCT00216502 · 2001-08-01
COMPLETEDPlacebo-Controlled Evaluation of Galantamine in the Treatment of Alzheimer's Disease: Safety and Efficacy of a Controlled-Release FormulationNCT00253214 · 2001-03-01
COMPLETEDA Study of the Safety and Effectiveness of Galantamine Versus Placebo in the Treatment of Patients With Vascular Dementia or Mixed DementiaNCT00261573 · 1998-12-01
COMPLETEDA Study of the Safety and Effectiveness of a Flexible Dose of Galantamine Versus Placebo in the Treatment of Patients With Alzheimer's DiseaseNCT00253227 · 1997-07-01
COMPLETEDA Study of the Safety and Effectiveness of Two Doses of Galantamine Versus Placebo in the Treatment of Patients With Alzheimer's DiseaseNCT00253188 · 1997-02-01
COMPLETEDA Study of the Safety and Effectiveness of Two Doses of Galantamine Versus Placebo in the Treatment of Patients With Alzheimer's DiseaseNCT00253201
COMPLETEDCommon conditions
Leading sponsors
Trial status mix
COMPLETED9
Phase mix
PHASE38
PHASE41
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.